4BASEBIO PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,080 GBX | 0.00% |
|
+0.93% | +58.82% |
| 04-10 | 4basebio to supply synthetic DNA for mRNA vaccine program | AN |
| 04-10 | 4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program | CI |
Chart calendar 4basebio PLC
fe85fa523c4a88c867ac1fdf24905399.Hwstwe2z9M9gOGqjOSMszwGR3zPDjoiv3yAUkhMhjk8.bk9GmIXxk4YUbF_NcWFVpFvguwGk1Mrns1VE3Gdm9C1QcmfzhebDhAJoPw~60bf46a67e013537a6ef1fcf25ecce00
Upcoming events on 4basebio PLC
Past events on 4basebio PLC
| 21/09/2023 07:00 | Q2 2023 Earnings Release |
| 16/06/2023 10:00 | Investor Meeting |
| 14/06/2023 09:00 | Annual General Meeting |
| 11/05/2023 07:00 | Q4 2022 Earnings Release |
| 30/09/2022 07:00 | Interim 2022 Earnings Release |
| 13/06/2022 10:00 | Investor Meeting |
| 09/06/2022 09:00 | Annual General Meeting |
| 09/05/2022 07:00 | FY 2021 Earnings Release |
| 30/09/2021 07:00 | Interim 2021 Earnings Release |
| 01/07/2021 10:00 | Investor Meeting |
| 30/06/2021 09:00 | Annual General Meeting |
| 03/06/2021 07:00 | FY 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,46 0,40 15.5% | 0,34 0,20 69% | 0,27 0,30 -10.67% | 0,50 |
|
EBITDA Million GBP | Released Forecast Spread | -0,35 -0,67 48.51% | -3,21 -3,20 -0.22% | -5,41 -5,10 -6.06% | -7,30 |
|
EBIT Million GBP | Released Forecast Spread | -0,62 -0,90 30.89% | -3,53 -3,50 -0.77% | -5,84 -5,60 -4.29% | -7,90 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -0,72 -1,01 29.11% | -3,64 -3,50 -4% | -5,93 -5,80 -2.22% | -8,50 |
|
Net income Million GBP | Released Forecast Spread | -0,72 -0,91 20.99% | -3,24 -3,20 -1.09% | -5,15 -5,20 0.96% | -7,70 |
|
EPS GBP | Released Forecast Spread | -0,08 -0,12 32.2% | -0,26 -0,26 1.52% | -0,42 -0,42 -0.24% | -0,60 |
| Announcement Date | 03/06/21 | 09/05/22 | 11/05/23 | - |
More events
Past sector events for 4basebio PLC
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4BB Stock
- Calendar 4basebio PLC
